President Donald Trump bought up to $5 million in Axon stock on Feb. 10. Just 14 days later, Immigration and Customs Enforcement posted a notice seeking a five-year, $220 million contract for about 17,800 Tasers. The notice called for an unlimited supply of cartridges and training, which would increase ICE's current stock of roughly 4,300 devices by over four times.
The timing raises questions about whether the president's personal finances overlap with his administration's decisions. The contract has not been awarded yet, but the facts on the table are hard to ignore.
Trump's purchase landed in the disclosure range of $1 million to $5 million.
Get your free investing masterclass bonus when you join Market Briefs, our free daily newsletter
The combination of personal stock profit and policy direction troubles ethics watchdogs. Jordan Libowitz, communications vice president for the watchdog organization CREW, told CNBC, "The concern is that [Trump] bought into a company whose business could grow if his own administration expands immigration enforcement."
Deborah Fleischaker, who previously served as acting ICE chief of staff under President Biden and now works as a senior immigration policy advisor at UnidosUS, commented, "What happened [in Minneapolis] showed how ICE agents have a hard job. The agency has a responsibility to make sure they have appropriate modern tools and training, but it's vital that new purchases are made for the right reasons." She added, "It is not smart to buy stock in a company that was impacted by the decisions you would be making at the agency. I would have stayed far, far away from actual impropriety, or the appearance of impropriety."
According to the White House, Trump's assets are placed in a trust overseen by his children, while independent third-party firms handle his investments rather than Trump or his family. Spokesperson Anna Kelly told CNBC, "There are no conflicts of interest," calling the scrutiny a "tired narrative" pushed by Democrats.
There is no proof that any contracting officials had knowledge of Trump's stock holdings, or that Axon was aware he owned shares. Trump's purchase occurred on Feb. 10, but it remained undisclosed until his financial report became public in May. The ICE notice followed standard federal procurement procedures. No contract has been awarded so far, and because the notice was an RFI, not a formal solicitation, no public record exists of which vendors may have replied.
Axon has stepped up its efforts to influence federal agencies, spending about $2.5 million on lobbying in the past year and bringing on a former senior Palantir employee as it expands its government division. Axon declined to answer questions about whether it had conversations with ICE, DHS, or White House staff regarding the possible Taser deal prior to the Feb. 24 notice.
Subscribe to Market Briefs, our free daily newsletter, and claim your bonus investing masterclass
